TAVI May Improve Cognitive Function in Patients with Prior Deterioration

Cognitive Function TAVIThis work studies cognitive evolution after transcatheter aortic valve implantation (TAVI). Previous smaller studies reported conflicting results on cognitive function after TAVI.

 

This study prospectively included 229 patients who were ≥70 years old, had undergone TAVI and were assessed using the Mini Mental State Examination before and 6 months after the procedure. Cognitive deterioration or improvement was defined as a decrease or increase in the Mini Mental State Examination score of at least 3 points between baseline and 6 months.

 

Cognitive deterioration was found in 29 patients (12.7%), although no statistically significant predictor of this event was identified. However, observation of the 8 patients with the highest deterioration score (Mini Mental State Examination score decrease of ≥5 points) revealed possible specific causes, such as postinterventional delirium, postinterventional stroke, progressive renal failure, progressive heart failure, or preexisting cerebrovascular disease.

 

There were 48 patients with baseline cognitive deterioration (Mini Mental State Examination score <26 points), of whom 18 (37.5%) improved significantly.

 

The preinterventional aortic valve area was lower in patients who cognitively improved after the procedure (mean baseline aortic valve area 0.6 cm²) when compared with patients whose score remained similar to their baseline score (mean baseline aortic valve area 0.7 cm²; p = 0.01).

 

Conclusion

This is the first study providing evidence that transcatheter aortic valve replacement may result in cognitive improvement among patients who had preprocedural cognitive impairment, which may be possibly related to hemodynamic improvement. This study also confirms that some patients experience cognitive deterioration after the procedure.

 

Original title: Evolution of Cognitive Function After Transcatheter Aortic Valve Implantation.

Reference: Andreas W. Schoenenberger et al. Circ Cardiovasc Interv. 2016 Oct;9(10).

 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...

Is Angioplasty Always Necessary after TAVR?

Courtesy of: Silvina E. Gomez, MD The prevalence of coronary artery disease (CAD) in patients undergoing TAVR is high, ranging from 40 to 70%, according...

TAVR and Anticoagulation: What Should We Do?

Transcatheter aortic valve replacement (TAVR) has consolidated as a valid strategy for certain groups of patients. However, approximately one third of those who require...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Bicuspid Valves: Higher Prosthesis Mismatch?

TAVR indication is steadily advancing onto younger, lower risk patients.  The presence of bicuspid aortic valves (BAV) has been observed in 0.5% to 2% of...

ROLLER COASTR-EPIC22: Comparison of Plaque Modification Techniques in Severely Calcified Coronary Lesions

The presence of coronary calcium significantly limits the success of percutaneous coronary interventions (PCI), primarily due to suboptimal stent expansion. This can lead to...

Edge-to-Edge Repair in Central and Non-Central Mitral Regurgitation

Mitral regurgitation (MR) is a common condition, with approximately 3.5% prevalence in individuals under 65, increasing to 7.7% in those over 75. It can...